Výsledky vyhledávání - "HIV Integrase Inhibitors/therapeutic use"

VIH: prévention, traitement et perspectives

Autor: Kampouri, Eleftheria, Papadimitriou-Olivgeris, Matthaios, Calmy, Alexandra, Ciuffi, Angela, Cavassini, Matthias

Publikováno v: Revue médicale suisse, Vol. 16, No 676-677 (2020) pp. 92-98

Cet article aborde les aspects préventifs, thérapeutiques et les perspectives de « guérison » du VIH. La PrEP se positionne comme un pilier essentiel pour contrôler l'épidémie. La bithérapie antirétrovirale visant à diminuer les toxicités

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d68ed3ab94facabe4cc58d71c4e08a
https://doi.org/10.53738/revmed.2020.16.676-77.0092

Zobrazit plný text záznamu

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

Publikováno v: Neesgaard, B, Mocroft, A, Zangerle, R, Wit, F, Lampe, F, Günthard, H F, Necsoi, C, Law, M, Mussini, C, Castagna, A, Monforte, A DA, Pradier, C, Chkhartisvilli, N, Reyes-Uruena, J, Vehreschild, J J, Wasmuth, J-C, Sönnerborg, A, Stephan, C, Greenberg, L, Llibre, J M, Volny-Anne, A, Peters, L, Pelchen-Matthews, A, Vannappagari, V, Gallant, J, Rieger, A, Youle, M, Braun, D, De Wit, S, Petoumenos, K, Borghi, V, Spagnuolo, V, Tsertsvadze, T, Lundgren, J, Ryom, L & RESPOND Study Group 2020, ' Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting : The RESPOND cohort consortium ', PLoS ONE, vol. 15, no. 12, e0243625 . https://doi.org/10.1371/journal.pone.0243625
PLoS ONE
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
PLoS ONE, Vol 15, Iss 12, p e0243625 (2020)
PLoS ONE, 15(12 December):e0243625. Public Library of Science
PloS one, 15 (12 December

Objectives To compare virologic and immunologic outcomes of integrase inhibitor (INSTI)-containing, contemporary boosted protease inhibitor (PI/b)-containing and non-nucleotide reverse transcriptase inhibitor (NNRTI)-containing regimens in a real-lif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b7e1131f1db9907055718899d452b1

Zobrazit plný text záznamu

Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection

Autor: Claudine Duvivier, Raphael Veil, Laurent Cotte, Laure Surgers, Antoine Cheret, Rémonie Seng, Caroline Lascoux Combe, Jacques Reynes, Laurence Meyer, Laurent Tran, David Rey, Clotilde Allavena, Isabelle Poizot-Martin, Pierre Delobel, Cécile Goujard

Publikováno v: AIDS
AIDS, Lippincott, Williams & Wilkins, 2020, 34 (4), pp.493-500. ⟨10.1097/QAD.0000000000002447⟩

International audience; Design: Current international guidelines recommend either boosted protease inhibitor (PI/r)-based or integrase inhibitors (INSTI)-based regimens during primary HIV infection (PHI), even though the latter have only demonstrated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4884625e388980901de465e7b1235fbe
https://pubmed.ncbi.nlm.nih.gov/31764069

Zobrazit plný text záznamu

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

Publikováno v: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 74 (5), pp.1368-1375. ⟨10.1093/jac/dkz021⟩
Journal of Antimicrobial Chemotherapy, 2019, 74 (5), pp.1368-1375. ⟨10.1093/jac/dkz021⟩

International audience; Objectives: To describe integrase strand transfer inhibitor (INSTI) resistance profiles and factors associated with resistance in antiretroviral-naive and -experienced patients failing an INSTI-based regimen in clinical practi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b81aa0dcf188502b617cb295d23cbb
https://hal-normandie-univ.archives-ouvertes.fr/hal-02154049

Zobrazit plný text záznamu

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study

Autor: Au, Scherrer, Wl, Yang, Rd, Kouyos, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Christoph Hauser, Calmy A, Schmid P, Bernasconi E, Hf, Günthard, Hiv, Swiss Cohort Study

Publikováno v: JOURNAL OF INFECTIOUS DISEASES
The Journal of Infectious Diseases, Vol. 214, No 3 (2016) pp. 399-402
Europe PubMed Central

The prevalence of integrase strand transfer inhibitor (INSTI)-transmitted drug resistance (TDR) may increase with the increasing use of INSTIs. We analyzed the prevalence of INSTI TDR in the Swiss HIV Cohort Study (2008-2014). In 1 of 1316 drug-naive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695e59d518a97d74034e54f8e6d6d244

Zobrazit plný text záznamu

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen

Autor: Cavaco-Silva, Joana, Abecasis, Ana, Miranda, Ana Cláudia, Poças, José, Narciso, Jorge, Águas, Maria João, Maltez, Fernando, Almeida, Isabel, Germano, Isabel, Diniz, António, Gonçalves, Maria de Fátima, Gomes, Perpétua, Cunha, Celso, Camacho, Ricardo Jorge, Portuguese HIV-2 Resistance Study Group

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
PLoS ONE; Vol 9
PLoS ONE, Vol 9, Iss 3, p e92747 (2014)
PLoS ONE

To characterize the HIV-2 integrase gene polymorphisms and the pathways to resistance of HIV-2 patients failing a raltegravir-containing regimen, we studied 63 integrase strand transfer inhibitors (INSTI)-naïve patients, and 10 heavily pretreated pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc852ea4a2ba0d9f2998182c0f546f51
http://dx.plos.org/10.1371/journal.pone.0092747

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání